Reference
Meltzer E, et al. Mitigating alemtuzumab-associated autoimmunity in MS: A "whack-a-mole" B-cell depletion strategy. Neurology: Neuroimmunology and NeuroInflammation 7: No. 6, Nov 2020. Available from: URL: http://doi.org/10.1212/NXI.0000000000000868
Rights and permissions
About this article
Cite this article
Alemtuzumab/rituximab. Reactions Weekly 1913, 31 (2022). https://doi.org/10.1007/s40278-022-18181-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-18181-5